These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2886223

  • 1. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP, McCue M, Freter S.
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anticholinergic effects on memory: benztropine versus amantadine.
    Gelenberg AJ, Van Putten T, Lavori PW, Wojcik JD, Falk WE, Marder S, Galvin-Nadeau M, Spring B, Mohs RC, Brotman AW.
    J Clin Psychopharmacol; 1989 Jun; 9(3):180-5. PubMed ID: 2661606
    [Abstract] [Full Text] [Related]

  • 4. A double-blind crossover comparison of antiparkinson drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function.
    McEvoy JP.
    J Clin Psychiatry; 1987 Sep; 48 Suppl():20-3. PubMed ID: 2887553
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of anticholinergic medication on memory in schizophrenia.
    Strauss ME, Reynolds KS, Jayaram G, Tune LE.
    Schizophr Res; 1990 Sep; 3(2):127-9. PubMed ID: 1980611
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum neuroleptic and anticholinergic activity in relationship to cognitive toxicity of antiparkinsonian agents in schizophrenic patients.
    Hitri A, Craft RB, Fallon J, Sethi R, Sinha D.
    Psychopharmacol Bull; 1987 Sep; 23(1):33-7. PubMed ID: 2885890
    [No Abstract] [Full Text] [Related]

  • 10. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
    Mori K, Yamashita H, Nagao M, Horiguchi J, Yamawaki S.
    Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients.
    Syndulko K, Gilden ER, Hansch EC, Potvin AR, Tourtellotte WW, Potvin JH.
    Int J Neurosci; 1981 Jan; 14(1-2):61-6. PubMed ID: 7263143
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.